Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
The recent newly listed Beijing Stock Exchange (BSE) IPOs are truly undervalued.
Recently, four newly listed stocks on the Beijing Stock Exchange have had modest opening-day gains. After listing, they all saw sharp declines. After falling for several days, the valuations are really low.
Longyuan Shares has a P/E ratio of 16; its current price is 33.67 yuan, up 36% from its issue price.
Puang Medical has a P/E ratio of 21; its current price is 36 yuan, up 96% from its issue price.
Yuelong Technology has a P/E ratio of 22; its current price is 24.28 yuan, up 72% from its issue price.
Xin Hengtai has a P/E ratio of 23; its current price is 15.9 yuan, up 69% from its issue price.
The P/E ratio of the BZSE 50 is 51. The valuations of these new stocks are all less than half of the BZSE 50. Because new listings on the Beijing Stock Exchange are issued at P/E ratios below 15, I thought that even if the BZSE 50 fell to 600 points, the new stocks wouldn’t go below the issue price. But now it looks like once it drops below 1000 points, they will go below the issue price.